HDAC9 and gastric cancer: The frequent loss of Brm expression has been observed in gastric cancer cell lines and primary gastric tumors, and this loss in its epxression is reversed by treatment with HDAC inhibitors in gastric cancer cell lines, suggesting the epigenetic regulation of this gene (63).